Glucose-Insulin-Potassium
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Glucose-Insulin-Potassium, covering 2013-10-11 to 2013-10-11. Get the full timeline:
Most recent: Clinical Trial Update: Effect of Glucose-Insulin-Potassium on Hyperlactatemia in Patients Undergoing Valvular Heart Surgery [NA]